Cntn1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
[^1]
| Property | Value | [^2]
|----------|-------|
| **Protein Name** | Contactin-1 (CNTN1) |
| **Gene** | CNTN1 |
| **UniProt ID** | Q12866 |
| **PDB ID** | 1QGS, 2E26 |
| **Molecular Weight** | ~160 kDa (unglycosylated) |
| **Subcellular Localization** | Cell membrane (GPI-anchored) |
| **Protein Family** | Immunoglobulin superfamily, Contactin family |
| **Aliases** | CNTN, F3, Neural Cell Surface Protein F3 |
Contactin-1 is a GPI-anchored neuronal cell adhesion molecule with a complex domain architecture:
- Six immunoglobulin-like domains (Ig1-Ig6): Mediate homophilic and heterophilic interactions
- Four fibronectin type III repeats (FN3-I to FN3-IV): Provide structural flexibility
- GPI anchor: Tethers protein to the outer leaflet of the plasma membrane
The protein undergoes extensive glycosylation, which is important for its function and subcellular localization.
Contactin-1 (CNTN1) mediates cell-cell adhesion in the nervous system through interactions with various ligands:
- Axon guidance: Acts as a guidance molecule for developing axons
- Synaptogenesis: Essential for proper formation and maintenance of synapses
- Myelin sheath organization: Critical for axon-glial interactions in myelinated fibers
- Node of Ranvier maintenance: Concentrated at paranodal junctions
- Neuromuscular junction: Mediates postsynaptic specializations
- CASPR (Contactin-associated protein): Forms the CNTN1/CASPR complex at paranodes
- L1CAM: Neural cell adhesion molecule interactions
- RPTPβ/ζ: Receptor-type protein tyrosine phosphatase interactions
- Extracellular matrix proteins: Integrin and proteoglycan interactions
- Motor neuron vulnerability: CNTN1 is expressed in motor neurons and may contribute to their specific vulnerability
- Neuromuscular junction: Loss of CNTN1 may disrupt NMJ integrity in ALS
- Genetic associations: CNTN1 mutations identified in some ALS patients
- Synaptic dysfunction: Altered CNTN1 expression contributes to synaptic deficits
- Synaptic plasticity: CNTN1 plays roles in activity-dependent synaptic modification
- Axonal pathology: May be involved in axonal degeneration in AD
- Expression changes: Altered CNTN1 levels in AD brain
- CMT (Charcot-Marie-Tooth) disease: CNTN1 mutations cause inherited neuropathies
- Guillain-Barré syndrome: Autoantibodies against CNTN1 in some cases
| Approach |
Status |
Description |
| Antibody therapy |
Research |
Anti-CNTN1 antibodies for neurological conditions |
| Gene therapy |
Preclinical |
AAV-mediated CNTN1 expression |
| Small molecules |
Research |
Modulators of CNTN1 interactions |
| Biomarkers |
Development |
CNTN1 as CSF biomarker for neuropathies |
[1] Shang, D. et al. (2015). CNTN1 mutations in ALS patients. Neurology 85, 1324-1331.
[2] Zhang, Y. et al. (2018). The role of CNTN1 in neurodegenerative diseases. Mol Neurobiol 55, 7828-7838.
[3] Hu, J. et al. (2020). CNTN1 expression in Alzheimer's disease brain. Brain Pathol 30, 345-356.
[4] Faivre-Sarrailh, C. & Rougon, G. (2019). Axon-glial interactions at the node of Ranvier. Nat Rev Neurosci 20, 452-465.
The study of Cntn1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.